MiNK Therapeutics, Inc. (INKT) has 14 open-market insider trades by 5 insiders since 2021. Over the last six months insiders net sold $92K. The most active filer is Agenus Inc., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Agenus Inc. | 10% Owner | — | 7 | $17.9M | 2023-10-16 |
| Garo H. Armen | Dir | — | 2 | $190K | 2023-05-05 |
| Barbara Ryan | CEO | — | 1 | $73K | 2026-10-12 |
| Barbara Ryan | Dir | — | 3 | $47K | 2026-06-04 |
| Ulf Wiinberg | Dir | — | 1 | $28K | 2026-06-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Barbara Ryan | CEO | Sell | $73K | 2026-10-12 |
| Barbara Ryan | Director | Sell | $19K | 2026-06-04 |
| Barbara Ryan | Director | Sell | $22K | 2026-03-09 |
| Barbara Ryan | Director | Sell | $5K | 2026-02-27 |
| Agenus Inc. | 10% | Buy | $25K | 2023-10-12 |
| Agenus Inc. | 10% | Buy | $16K | 2023-10-04 |
Companies that share insiders with INKT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Agenus Inc. | 10% | Buy | $45K | 2023-08-29 |
| Agenus Inc. | 10% Owner | Buy | $543K | 2023-08-24 |
| Agenus Inc. | 10% | Buy | $67K | 2023-05-10 |
| Garo H. Armen | Director | Sell | $95K | 2023-05-05 |
| Agenus Inc. | 10% Owner | Buy | $399K | 2023-05-03 |
| Garo H. Armen | Director | Buy | $95K | 2023-05-02 |
| Ulf Wiinberg | Director | Buy | $28K | 2022-07-18 |
| Agenus Inc. | 10% Owner | Buy | $16.8M | 2021-10-19 |